Page last updated: 2024-11-05

troglitazone and Berger Disease

troglitazone has been researched along with Berger Disease in 1 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xiao, J1
Leung, JC1
Chan, LY1
Guo, H1
Lai, KN1

Other Studies

1 other study available for troglitazone and Berger Disease

ArticleYear
Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:7

    Topics: Cells, Cultured; Chromans; Epithelial Cells; Female; Glomerulonephritis, IGA; Humans; Inflammation;

2009